230 related articles for article (PubMed ID: 30790117)
1. Host factors influence Barrett's carcinogenesis: findings from a mouse gastroduodenal reflux model.
Kanai S; Mukaisho KI; Yoshida S; Taniura N; Sugihara H
Esophagus; 2019 Jul; 16(3):264-271. PubMed ID: 30790117
[TBL] [Abstract][Full Text] [Related]
2. High animal-fat intake changes the bile-acid composition of bile juice and enhances the development of Barrett's esophagus and esophageal adenocarcinoma in a rat duodenal-contents reflux model.
Chen KH; Mukaisho K; Sugihara H; Araki Y; Yamamoto G; Hattori T
Cancer Sci; 2007 Nov; 98(11):1683-8. PubMed ID: 17868414
[TBL] [Abstract][Full Text] [Related]
3. Animal Model: Reflux Models in Esophageal Adenocarcinoma.
Masuda T; Mittal SK
Methods Mol Biol; 2018; 1756():143-150. PubMed ID: 29600367
[TBL] [Abstract][Full Text] [Related]
4. From Reflux Esophagitis to Esophageal Adenocarcinoma.
Souza RF
Dig Dis; 2016; 34(5):483-90. PubMed ID: 27331918
[TBL] [Abstract][Full Text] [Related]
5. Acidic Bile Salts Induce Epithelial to Mesenchymal Transition via VEGF Signaling in Non-Neoplastic Barrett's Cells.
Zhang Q; Agoston AT; Pham TH; Zhang W; Zhang X; Huo X; Peng S; Bajpai M; Das K; Odze RD; Spechler SJ; Souza RF
Gastroenterology; 2019 Jan; 156(1):130-144.e10. PubMed ID: 30268789
[TBL] [Abstract][Full Text] [Related]
6. Rat Reflux Model of Esophageal Cancer and Its Implication in Human Disease.
Greene CL; Worrell SG; DeMeester TR
Ann Surg; 2015 Dec; 262(6):910-24. PubMed ID: 25822684
[TBL] [Abstract][Full Text] [Related]
7. Gene expression changes associated with Barrett's esophagus and Barrett's-associated adenocarcinoma cell lines after acid or bile salt exposure.
Hao Y; Sood S; Triadafilopoulos G; Kim JH; Wang Z; Sahbaie P; Omary MB; Lowe AW
BMC Gastroenterol; 2007 Jun; 7():24. PubMed ID: 17597535
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms of oxidant production in esophageal squamous cell and Barrett's cell lines.
Feagins LA; Zhang HY; Zhang X; Hormi-Carver K; Thomas T; Terada LS; Spechler SJ; Souza RF
Am J Physiol Gastrointest Liver Physiol; 2008 Feb; 294(2):G411-7. PubMed ID: 18063706
[TBL] [Abstract][Full Text] [Related]
9. Toll-like Receptor 2 Signalling and the Lysosomal Machinery in Barrett's Esophagus.
Verbeek RE; Siersema PD; Vleggaar FP; Ten Kate FJ; Posthuma G; Souza RF; de Haan J; van Baal JW
J Gastrointestin Liver Dis; 2016 Sep; 25(3):273-82. PubMed ID: 27689189
[TBL] [Abstract][Full Text] [Related]
10. Fatty acid synthase expression in Barrett's esophagus: implications for carcinogenesis.
Ishimura N; Amano Y; Sanchez-Siles AA; Fukuhara H; Takahashi Y; Uno G; Tamagawa Y; Mishima Y; Yuki T; Ishihara S; Kinoshita Y
J Clin Gastroenterol; 2011 Sep; 45(8):665-72. PubMed ID: 21325951
[TBL] [Abstract][Full Text] [Related]
11. Factors influencing the development of Barrett's epithelium in the esophageal remnant postesophagectomy.
O'Riordan JM; Tucker ON; Byrne PJ; McDonald GS; Ravi N; Keeling PW; Reynolds JV
Am J Gastroenterol; 2004 Feb; 99(2):205-11. PubMed ID: 15046206
[TBL] [Abstract][Full Text] [Related]
12. Bile acids but not acidic acids induce Barrett's esophagus.
Sun D; Wang X; Gai Z; Song X; Jia X; Tian H
Int J Clin Exp Pathol; 2015; 8(2):1384-92. PubMed ID: 25973022
[TBL] [Abstract][Full Text] [Related]
13. Bile acid exposure up-regulates tuberous sclerosis complex 1/mammalian target of rapamycin pathway in Barrett's-associated esophageal adenocarcinoma.
Yen CJ; Izzo JG; Lee DF; Guha S; Wei Y; Wu TT; Chen CT; Kuo HP; Hsu JM; Sun HL; Chou CK; Buttar NS; Wang KK; Huang P; Ajani J; Hung MC
Cancer Res; 2008 Apr; 68(8):2632-40. PubMed ID: 18413730
[TBL] [Abstract][Full Text] [Related]
14. Effect of gastroduodenal juice and dietary fat on the development of Barrett's esophagus and esophageal neoplasia: an experimental rat model.
Clark GW; Smyrk TC; Mirvish SS; Anselmino M; Yamashita Y; Hinder RA; DeMeester TR; Birt DF
Ann Surg Oncol; 1994 May; 1(3):252-61. PubMed ID: 7842295
[TBL] [Abstract][Full Text] [Related]
15. Molecular biology of Barrett's cancer.
Atherfold PA; Jankowski JA
Best Pract Res Clin Gastroenterol; 2006; 20(5):813-27. PubMed ID: 16997163
[TBL] [Abstract][Full Text] [Related]
16. [Adenocarcinoma of the esophagogastric junction: association with Barrett esophagus and gastroesophageal reflux--surgical results in 122 patients].
Schumpelick V; Dreuw B; Ophoff K; Fass J
Leber Magen Darm; 1996 Mar; 26(2):75-6, 79-80, 83-6. PubMed ID: 8684248
[TBL] [Abstract][Full Text] [Related]
17. Bile acid-induced "Minority MOMP" promotes esophageal carcinogenesis while maintaining apoptotic resistance via Mcl-1.
Xu Y; Surman DR; Diggs L; Xi S; Gao S; Gurusamy D; McLoughlin K; Drake J; Feingold P; Brown K; Wangsa D; Wangsa D; Zhang X; Ried T; Davis JL; Hernandez J; Hoang CD; Souza RF; Schrump DS; Taylor Ripley R
Oncogene; 2020 Jan; 39(4):877-890. PubMed ID: 31570787
[TBL] [Abstract][Full Text] [Related]
18. Determination of risk for Barrett's esophagus and esophageal adenocarcinoma.
Thrift AP
Curr Opin Gastroenterol; 2016 Jul; 32(4):319-24. PubMed ID: 27276368
[TBL] [Abstract][Full Text] [Related]
19. Bile acids induce overexpression of homeobox gene CDX-2 and vascular endothelial growth factor (VEGF) in human Barrett's esophageal mucosa and adenocarcinoma cell line.
Burnat G; Rau T; Elshimi E; Hahn EG; Konturek PC
Scand J Gastroenterol; 2007 Dec; 42(12):1460-5. PubMed ID: 17852856
[TBL] [Abstract][Full Text] [Related]
20. High-Fat Diet Accelerates Carcinogenesis in a Mouse Model of Barrett's Esophagus via Interleukin 8 and Alterations to the Gut Microbiome.
Münch NS; Fang HY; Ingermann J; Maurer HC; Anand A; Kellner V; Sahm V; Wiethaler M; Baumeister T; Wein F; Einwächter H; Bolze F; Klingenspor M; Haller D; Kavanagh M; Lysaght J; Friedman R; Dannenberg AJ; Pollak M; Holt PR; Muthupalani S; Fox JG; Whary MT; Lee Y; Ren TY; Elliot R; Fitzgerald R; Steiger K; Schmid RM; Wang TC; Quante M
Gastroenterology; 2019 Aug; 157(2):492-506.e2. PubMed ID: 30998992
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
